The role of splenectomy in splenic marginal zone B-cell lymphoma.
Center for Biologics Evaluation and Research Food and Drug Administration National Institutes of Health Bethesda, MD, USA.
Gerald E
GE
Marti
D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000601:surgery*; D012189:Retrospective Studies; D013156:Splenectomy; D013160:Splenic Neoplasms / Q000188:drug therapy / Q000601:surgery*; D016896:Treatment Outcome
D000970:Antineoplastic Agents